Ignite Creation Date:
2025-12-25 @ 1:46 AM
Ignite Modification Date:
2026-03-25 @ 4:50 AM
Study NCT ID:
NCT05468294
Status:
UNKNOWN
Last Update Posted:
2022-07-21
First Post:
2022-06-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Sponsor:
Philogen S.p.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PH-F16IL2PD1-01/16
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None